(2S)-2,3,4,4-Tetraformyl-2-[[4-[2-(2-formyltetrazol-5-yl)phenyl]phenyl]methyl-pentanoylamino]-3-methyl-5-oxopentanoic acid
(XTRFGYALRKMJOY-TXDWVUBVSA-N)
Structure
- SMILES
- CCCCC(=O)N([C@](C(C(C=O)(C=O)C=O)(C=O)C)(C(=O)O)C=O)Cc1ccc(cc1)c1ccccc1c1nnn(n1)C=O
- Molecular Formula:
- C30H29N5O9
- Molecular Weight:
- 603.579
- Log P:
- 1.9769
- Hydrogen Bond Acceptor:
- 14
- Hydrogen Bond Donor:
- 1
- TPSA:
- 203.63
- CAS Number(s):
- N/A
Synonym(s)
1.
(2S)-2,3,4,4-Tetraformyl-2-[[4-[2-(2-formyltetrazol-5-yl)phenyl]phenyl]methyl-pentanoylamino]-3-methyl-5-oxopentanoic acid
External Link(s)
| PubChem Compound | 129642511 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Angioedema | FAERS: 1 | US FAERS | |
| 2 | Cholangiocarcinoma | FAERS: 1 | US FAERS | |
| 3 | Neutropenia | FAERS: 1 | US FAERS | |
| 4 | Product substitution issue | FAERS: 1 | US FAERS | |
| 5 | Restlessness | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.